Call us for quotes at (610) 458-1112 or 
Email us at primbiobiz@primbioresearch.com
PRIMBIO
  • Home
  • Company
    • About Us
    • Our Team
    • Publications
    • Careers
  • Technology
    • Illumina NextSeq 2000
    • Ion GeneStudio™ S5 Prime System
    • QuantStudio™ 12K PCR System
  • Research Services
    • RNA-seq
    • Exome Sequencing
    • Gene Panels
    • 16S Metagenomic Sequencing
    • Real-time qPCR
  • Clinical Tests
    • UTI QPCR TEST
    • COVID/FLU/RSV RT-PCR TEST
  • Get a Quote
  • Home
  • Company
    • About Us
    • Our Team
    • Publications
    • Careers
  • Technology
    • Illumina NextSeq 2000
    • Ion GeneStudio™ S5 Prime System
    • QuantStudio™ 12K PCR System
  • Research Services
    • RNA-seq
    • Exome Sequencing
    • Gene Panels
    • 16S Metagenomic Sequencing
    • Real-time qPCR
  • Clinical Tests
    • UTI QPCR TEST
    • COVID/FLU/RSV RT-PCR TEST
  • Get a Quote

Primbio Breast CANCER Therapy Panel

Breast cancer is the most common cancer in women. 5-10% of breast cancers can be linked to gene mutations inherited from either parent.  The most common genes mutated in inherited breast cancer are BRCA1 and BRAC2.  However, there are also other genes associated with inherited breast cancer.  Next Generation Sequencing makes it possible to test these genes across their entire exonic regions. Mutations in these genes provide important information regarding tumor development, tumor progression, and can be used as a reliable predictor of personalized cancer therapies.  We have developed a Breast Cancer Panel that includes 31 genes associated with breast cancer.  This panel is designed to help doctors determine which patients have a high risk of developing breast cancer.
Molecular Diagnostic
​ Requisition Form
Hereditary Test
​Questionnaire
Sample Submission
​Guidelines
Powered by Create your own unique website with customizable templates.